Valuation: Virbac

Market Cap 254.38Cr 289.89Cr 240.25Cr 218.95Cr 409.86Cr 28TCr 412.78Cr 2.88TCr 1.11TCr 14TCr 1.09TCr 1.06TCr 46TCr P/E 2026 *
14.7x
P/E 2027 * 13.2x
Enterprise Value 266.62Cr 303.84Cr 251.81Cr 229.48Cr 429.58Cr 29TCr 432.64Cr 3.01TCr 1.17TCr 15TCr 1.14TCr 1.12TCr 48TCr EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.57x
Free-Float
49.03%
Yield 2026 *
0.57%
Yield 2027 * 0.67%
1 day+0.50%
1 week-2.25%
Current month-5.89%
1 month-8.58%
3 months-11.26%
6 months-14.63%
Current year-15.10%
1 week 301
Extreme 301
312.5
1 month 297
Extreme 297
327
Current year 297
Extreme 297
389.5
1 year 297
Extreme 297
389.5
3 years 242
Extreme 242
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Date Insider Type Main position Quantity % Market Cap. Importance
22/04/24 Sell

Chief Executive Officer

810 0.0096%
22/04/24 Sell

Chief Executive Officer

140 0.0017%
22/04/24 Sell

Chief Executive Officer

1,688 0.0200%
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%-2.25%-3.19%+22.87% 289.89Cr
+1.11%-0.49%-50.49%-59.83% 2.94TCr
-0.18%-0.49%+13.77%+96.56% 1.11TCr
-3.46%-2.53%-14.13%-2.88% 370.7Cr
+0.71%+0.71%+23.27%+47.11% 189.99Cr
-2.98%-2.81%+22.06%+22.06% 185.08Cr
+1.53%-0.32%-11.23%+164.80% 139.87Cr
-2.80%-0.60%-20.40%-8.96% 112.69Cr
-0.60%+0.30%-5.95%-40.29% 101.01Cr
0.00%+2.58%-2.33%-1.95% 100Cr
Average -0.62%-0.59%-4.86%+23.95% 553.98Cr
Weighted average by Cap. +0.24%-0.68%-24.41%-5.71%

Financials

2026 *2027 *
Net sales 154.73Cr 176.33Cr 146.13Cr 133.17Cr 249.29Cr 17TCr 251.07Cr 1.75TCr 677.31Cr 8.63TCr 662.04Cr 647.72Cr 28TCr 164.43Cr 187.38Cr 155.29Cr 141.52Cr 264.92Cr 18TCr 266.81Cr 1.86TCr 719.77Cr 9.18TCr 703.55Cr 688.33Cr 29TCr
Net income 17Cr 20Cr 16Cr 15Cr 28Cr 1.9TCr 28Cr 196.54Cr 76Cr 970.38Cr 74Cr 73Cr 3.12TCr 19Cr 22Cr 18Cr 17Cr 31Cr 2.12TCr 31Cr 218.95Cr 85Cr 1.08TCr 83Cr 81Cr 3.47TCr
Net Debt 12Cr 14Cr 12Cr 11Cr 20Cr 1.34TCr 20Cr 138.33Cr 54Cr 682.98Cr 52Cr 51Cr 2.2TCr 4.47Cr 5.1Cr 4.22Cr 3.85Cr 7.21Cr 488.44Cr 7.26Cr 51Cr 20Cr 249.54Cr 19Cr 19Cr 801.98Cr
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
25/26/25 €303.50 +0.50% 4,384
24/26/24 €302.00 -0.82% 4,422
23/26/23 €304.50 -0.98% 6,681
22/26/22 €307.50 0.00% 6,826
21/26/21 €307.50 -0.97% 4,906
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
303.50EUR
Average target price
412.75EUR
Spread / Average Target
+36.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock